SEC tests insider-trading theory at trial of ex-Bay Area biotech executive
By Rachel Graf | Bloomberg A lawyer for the US Securities and Exchange Commission told a jury that a former biotech executive’s $120,000 windfall on a trade in a competing company’s stock was “like betting on a game when you …
SEC tests insider-trading theory at trial of ex-Bay Area biotech executive Read More